| Entry |
|
| Name |
Deleted p16(INK4a) to p16-cell cycle G1/S
|
| Definition |
CDKN2A* // (CCND+CDK4/6) -> RB1 // E2F |
| Expanded |
1029v1 // ((595,894,896)+(1019,1021)) -> 5925 // (1869,1870,1871) |
| Class |
|
| Type |
Variant
|
| Pathway |
|
| Disease |
| H00048 | Hepatocellular carcinoma |
|
| Gene |
| 1029 | CDKN2A; cyclin dependent kinase inhibitor 2A |
| 1019 | CDK4; cyclin dependent kinase 4 |
| 1021 | CDK6; cyclin dependent kinase 6 |
| 5925 | RB1; RB transcriptional corepressor 1 |
| 1869 | E2F1; E2F transcription factor 1 |
| 1870 | E2F2; E2F transcription factor 2 |
| 1871 | E2F3; E2F transcription factor 3 |
|
| Variant |
1029v1 (CDKN2A*) CDKN2A deletion
|
| Reference |
|
| Authors |
Schmid RM. |
| Title |
Genetic basis of pancreatic cancer. |
| Journal |
|
| Reference |
|
| Authors |
Bansal K, Liang ML, Rutka JT. |
| Title |
Molecular biology of human gliomas. |
| Journal |
|
| Reference |
|
| Authors |
Miller AJ, Mihm MC Jr. |
| Title |
Melanoma. |
| Journal |
|
| Reference |
|
| Authors |
Wolff EM, Liang G, Jones PA. |
| Title |
Mechanisms of Disease: genetic and epigenetic alterations that drive bladder cancer. |
| Journal |
|
| Reference |
|
| Authors |
Lee JS |
| Title |
The mutational landscape of hepatocellular carcinoma. |
| Journal |
|
| Reference |
|
| Authors |
Kudo M |
| Title |
Signaling pathway and molecular-targeted therapy for hepatocellular carcinoma. |
| Journal |
|
| LinkDB |
|